13:44 EDT Tenax Therapeutics (TENX) trading resumes
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TENX:
- Tenax Therapeutics trading halted, volatility trading pause
- Tenax Therapeutics Approves Officer Exculpation Amendment
- Tenax Therapeutics Reports Increased Losses Amid Strategic Investments
- Positive Buy Rating for Tenax Therapeutics Driven by Promising Clinical Trials and Strong Financial Position
- Tenax Therapeutics price target lowered to $15 from $16 at Guggenheim